FIELD: biotechnology.
SUBSTANCE: described is an immuno-binding molecule containing: CDR1, CDR2 and CDR3 of a light chain from a donor immunobinding molecule of a hare-like and CDR1, CDR2 and CDR3 of a heavy chain from a donor immunobinding molecule of a hare-like; a human light chain variable region framework and a human heavy chain variable region framework which is at least 85 % identical to the sequence SEQ ID NO: 4 and contains threonine (T) in position 24 (numbering AHo). Also disclosed is a method for humanizing said immunobinding molecule.
EFFECT: claimed molecule is suitable for some diagnostic and therapeutic applications.
19 cl, 6 dwg, 9 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
HUMANIZATION OF RABBIT ANTIBODIES USING THE UNIVERSAL ANTIBODY FRAME | 2014 |
|
RU2652907C2 |
HUMANISATION OF RABBIT ANTIBODIES USING UNIVERSAL ANTIBODY SCAFFOLD | 2009 |
|
RU2567006C2 |
VEGF INHIBITING STABLE AND SOLUBLE ANTIBODIES | 2009 |
|
RU2531523C9 |
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2016 |
|
RU2648152C2 |
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2009 |
|
RU2588467C2 |
STABLE AND SOLUBLE VEGF INHIBITING ANTIBODIES | 2018 |
|
RU2696972C1 |
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα | 2018 |
|
RU2678120C1 |
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα | 2009 |
|
RU2653753C1 |
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα | 2009 |
|
RU2567100C2 |
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFΑ | 2018 |
|
RU2704838C1 |
Authors
Dates
2019-07-31—Published
2018-03-19—Filed